The roles of Smad2 and Smad3 in the development of chemically induced skin tumors in mice

Veterinary Pathology

Volumn 41, Issue 3, 2004, Pages 278-282

  Tannehill Gregg, S H ^b   Kusewitt, D F ^b   Rosol, T J ^b   Weinstein, M ^a  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b NONE

Author keywords

Dimethylbenzanthracene; Keratinocytes; Mice; Papilloma; Squamous cell carcinoma; Transforming growth factor beta

Indexed keywords

DIMETHYLBENZ[A]ANTHRACENE; SMAD2 PROTEIN; SMAD3 PROTEIN;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; GENE DELETION; GENE DISRUPTION; HETEROZYGOSITY; HISTOPATHOLOGY; IMMUNOCYTOCHEMISTRY; MOUSE; NONHUMAN; ONCOGENE; SIGNAL TRANSDUCTION; SKIN CARCINOGENESIS; SKIN TUMOR; TRANSGENIC MOUSE; TUMOR DIFFERENTIATION; TUMOR SUPPRESSOR GENE; WILD TYPE;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; CARCINOGENS; CARCINOMA, SQUAMOUS CELL; DISEASE MODELS, ANIMAL; DNA-BINDING PROTEINS; HISTOLOGICAL TECHNIQUES; IMMUNOHISTOCHEMISTRY; MICE; MICE, TRANSGENIC; PAPILLOMA; SIGNAL TRANSDUCTION; SKIN NEOPLASMS; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANS-ACTIVATORS; TRANSFORMING GROWTH FACTOR BETA;

ANIMALIA; MUS MUSCULUS;

EID: 2542450984     PISSN: 03009858     EISSN: None     Source Type: Journal    
DOI: 10.1354/vp.41-3-278     Document Type: Article

References (21)

1. Ashcroft GS, Yang X, Glick AB, Weinstein M, Letterio JL, Mizel DE, Anzano M, Greenwell-Wild T, Wahl SM, Deng C, Roberts AB: Mice lacking Smad3 show accelerated wound healing and an impaired local inflammatory response. Nat Cell Biol 1:260-266, 1999
2. Bonyadi M, Rusholme SA, Cousins FM, Su HC, Biron CA, Farrall M, Akhurst RJ: Mapping of a major genetic modifier of embryonic lethality in TGF beta 1 knockout mice. Nat Genet 15:207-211, 1997
3. Cui W, Fowlis DJ, Bryson S, Duffle E, Ireland H, Balmain A, Akhurst RJ: TGFbetal inhibits the formation of benign skin tumors, but enhances progression to invasive spindle carcinomas in transgenic mice. Cell 86:531-542, 1996
4. Duff EK, Clarke AR: Smad4 (DPC4)-a potent tumour suppressor? Br J Cancer 78:1615-1619, 1998
5. Eppert K, Scherer SW, Ozcelik H, Pirone R, Hoodless P, Kim H, Tsui LC, Bapat B, Gallinger S, Andrulis IL, Thomsen GH, Wrana JL, Attisano L: MADR2 maps to 18q21 and encodes a TGFbeta-regulated MAD-related protein that is functionally mutated in colorectal carcinoma. Cell 86:543-552, 1996
6. Flanders KC, Sullivan CD, Fujii M, Sowers A, Anzano MA, Arabshahi A, Major C, Deng C, Russo A, Mitchell JB, Roberts AB: Mice lacking Smad3 are protected against cutaneous injury induced by ionizing radiation. Am J Pathol 160:1057-1068, 2002
7. Gkonos PJ, Hayes T, Burtis W, Jacoby R, McGuire J, Baron R, Stewart AF: Squamous carcinoma model of humoral hypercalcemia of malignancy. Endocrinology 115:2384-2390, 1984
8. He W, Cao T, Smith DA, Myers TE, Wang XJ: Smads mediate signaling of the TGFbeta superfamily in normal keratinocytes but are lost during skin chemical carcinogenesis. Oncogene 20:471-483, 2001
9. Moustakas A, Souchelnytskyi S, Heldin CH: Smad regulation in TGF-beta signal transduction. J Cell Sci 114: 4359-4369, 2001
10. Muro-Cacho CA, Rosario-Ortiz K, Livingston S, Munoz-Antonia T: Defective transforming growth factor beta signaling pathway in head and neck squamous cell carcinoma as evidenced by the lack of expression of activated Smad2. Clin Cancer Res 7:1618-1626, 2001
11. Nakao A, Imamura T, Souchelnytskyi S, Kawabata M, Ishisaki A, Oeda E, Tamaki K, Hanai J, Heldin CH, Miyazono K, ten Dijke P: TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4. EMBO J 16: 5353-5362, 1997
12. Verrecchia F, Chu ML, Mauviel A: Identification of novel TGF-beta/Smad gene targets in dermal fibroblasts using a combined cDNA microarray/promoter transactivation approach. J Biol Chem 276:17058-17062, 2001
13. Wang XJ: Role of TGF-beta signaling in skin carcinogenesis. Microsc Res Tech 52:420-429, 2001
14. Weinstein M, Monga SP, Liu Y, Brodie SG, Tang Y, Li C, Mishra L, Deng CX: Smad proteins and hepatocyte growth factor control parallel regulatory pathways that converge on betal-integrin to promote normal liver development. Mol Cell Biol 21:5122-5131, 2001.
15. Weinstein M, Yang X, Deng C: Functions of mammalian Smad genes as revealed by targeted gene disruption in mice. Cytokine Growth Factor Rev 11:49-58, 2000
16. Weinstein M, Yang X, Li C, Xu X, Gotay J, Deng CX: Failure of egg cylinder elongation and mesoderm induction in mouse embryos lacking the tumor suppressor smad2. Proc Natl Acad Sci USA 95:9378-9383, 1998
17. Wieser R: The transforming growth factor-beta signaling pathway in tumorigenesis. Curr Opin Oncol 13:70-77, 2001
18. Yang X, Letterio JJ, Lechleider RJ, Chen L, Hayman R, Gu H, Roberts AB, Deng C: Targeted disruption of SMAD3 results in impaired mucosal immunity and diminished T cell responsiveness to TGF-beta. EMBO J 18:1280-1291, 1999
19. Yuan W, Varga J: Transforming growth factor-beta repression of matrix metalloproteinase-1 in dermal fibroblasts involves Smad3. J Biol Chem 276:38502-38510, 2001
20. Yuspa SH, Dlugosz AA, Cheng CK, Denning MF, Tennenbaum T, Glick AB, Weinberg WC: Role of oncogenes and tumor suppressor genes in multistage carcinogenesis. J Invest Dermatol 103:908-958, 1994
21. Zhu Y, Richardson JA, Parada LF, Graff JM: Smad3 mutant mice develop metastatic colorectal cancer. Cell 94: 703-714, 1998